Alexza's Last Stand: Hoping For Buyout Or License Of Adasuve
This article was originally published in The Pink Sheet Daily
Executive Summary
Facing a potential shutdown at the end of April, the California drug-delivery firm hopes either to be purchased by its Spanish partner or find a new licensee of US rights to its inhalable antipsychotic.